TEVA · Teva Pharmaceutical Industries Ltd · Documents
Market Cap
$46.21B
Shares
1.17B
Volume · Oct 21
4.6M
Avg daily vol (3M)
5.68M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2021-07-28 | 2021-06-30 | |
| 8-K | — | 2021-07-21 | — | |
| 8-K | — | 2021-07-06 | 2021-07-02 | |
| 8-K | — | 2021-06-14 | — | |
| 8-K | — | 2021-04-28 | 2021-03-31 | |
| 10-Q | — | 2021-04-28 | 2021-03-31 | |
| DEFA14A | — | 2021-04-21 | — | |
| DEF 14A | — | 2021-04-21 | 2021-06-14 | |
| 8-K | — | 2021-02-10 | — | |
| 10-K | — | 2021-02-10 | 2020-12-31 | |
| 8-K | — | 2021-02-02 | 2021-01-31 | |
| 8-K | — | 2021-01-25 | 2021-01-21 | |
| 8-K | — | 2020-11-05 | — | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-08-06 | 2020-08-04 | |
| S-4 | — | 2020-08-05 | — | |
| 10-Q | — | 2020-08-05 | 2020-06-30 | |
| 8-K | — | 2020-08-05 | — | |
| 8-K | — | 2020-06-09 | — | |
| DEFA14A | — | 2020-05-26 | — | |
| 10-Q | — | 2020-05-07 | 2020-03-31 | |
| 8-K | — | 2020-05-07 | — | |
| DEFA14A | — | 2020-04-22 | — | |
| DEF 14A | — | 2020-04-22 | 2020-06-09 | |
| PRE 14A | — | 2020-03-19 | 2020-06-09 | |
| 10-K | — | 2020-02-21 | 2019-12-31 | |
| 8-K | — | 2020-02-12 | — |
Showing 101–127 of 127 filings
Key facts
CIK
818686
CUSIP
M8769Q102
13F (30d)
98 filings
86 filers
Visit website
Investor relations